mexiletine has been researched along with Familial Periodic Paralysis in 4 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Excerpt | Relevance | Reference |
---|---|---|
"Skeletal muscle ion channelopathies are rare genetic diseases mainly characterized by myotonia (muscle stiffness) or periodic paralysis (muscle weakness)." | 3.01 | Drug repurposing in skeletal muscle ion channelopathies. ( Altamura, C; Campanale, C; Desaphy, JF; Laghetti, P; Saltarella, I, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Altamura, C | 2 |
Saltarella, I | 2 |
Campanale, C | 2 |
Laghetti, P | 2 |
Desaphy, JF | 3 |
Sah, RL | 1 |
Tsushima, RG | 1 |
Backx, PH | 1 |
De Luca, A | 1 |
Tortorella, P | 1 |
De Vito, D | 1 |
George, AL | 1 |
Conte Camerino, D | 1 |
Takahashi, MP | 1 |
Cannon, SC | 1 |
1 review available for mexiletine and Familial Periodic Paralysis
Article | Year |
---|---|
Drug repurposing in skeletal muscle ion channelopathies.
Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio | 2023 |
Drug repurposing in skeletal muscle ion channelopathies.
Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio | 2023 |
Drug repurposing in skeletal muscle ion channelopathies.
Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio | 2023 |
Drug repurposing in skeletal muscle ion channelopathies.
Topics: Channelopathies; Dichlorphenamide; Drug Repositioning; Humans; Mexiletine; Muscle, Skeletal; Mutatio | 2023 |
3 other studies available for mexiletine and Familial Periodic Paralysis
Article | Year |
---|---|
Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation.
Topics: Anesthetics, Local; Animals; Benzocaine; Electrophysiology; Female; Horse Diseases; Horses; Hyperkal | 1998 |
Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.
Topics: Cell Line, Transformed; DNA Mutational Analysis; Dose-Response Relationship, Drug; Humans; Ion Chann | 2001 |
Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
Topics: Binding, Competitive; Cell Line; Computer Simulation; Electric Stimulation; Humans; Ion Channel Gati | 2001 |